FDA guidelines – Page 29

Inadequate protocols for evaluating shell-to-fill interaction effects.

Inadequate protocols for evaluating shell-to-fill interaction effects. Inadequate Protocols for Evaluating Shell-to-Fill Interaction Effects in Capsules Introduction: In the pharmaceutical industry, solid oral dosage forms such as capsules are a…

Poor validation of emergency power systems for critical utility systems.

Poor validation of emergency power systems for critical utility systems. Poor Validation of Emergency Power Systems for Critical Utility Systems Introduction: In the pharmaceutical industry, maintaining an uninterrupted power supply…

Poor adhesion of tamper-evident seals to capsule containers.

Poor adhesion of tamper-evident seals to capsule containers. Poor adhesion of tamper-evident seals to capsule containers. Introduction: The pharmaceutical industry places a high premium on ensuring the safety and integrity…

Challenges in validating cleaning processes for low-dose formulations.

Challenges in validating cleaning processes for low-dose formulations. Challenges in validating cleaning processes for low-dose formulations. Introduction: In the pharmaceutical industry, ensuring that equipment used in the manufacturing of drug…

Problems with ensuring consistent capsule wall thickness.

Problems with ensuring consistent capsule wall thickness. Problems with Ensuring Consistent Capsule Wall Thickness Introduction: In the pharmaceutical industry, capsules are a prevalent dosage form, prized for their ability to…

High downtime of packing lines due to frequent equipment breakdowns.

High downtime of packing lines due to frequent equipment breakdowns. High Downtime of Packing Lines Due to Frequent Equipment Breakdowns Introduction: In the pharmaceutical industry, maintaining efficient and uninterrupted production…

Poor validation of compressed air systems for particulate contamination.

Poor validation of compressed air systems for particulate contamination. Poor validation of compressed air systems for particulate contamination. Introduction: In the pharmaceutical industry, maintaining the integrity and purity of solid…

Poor enforcement of corrective and preventive action (CAPA) programs.

Poor enforcement of corrective and preventive action (CAPA) programs. Poor enforcement of corrective and preventive action (CAPA) programs. Introduction: Corrective and Preventive Action (CAPA) programs serve as a cornerstone in…

Challenges in validating capsule filling for powders with poor flow properties.

Challenges in validating capsule filling for powders with poor flow properties. Challenges in Validating Capsule Filling for Powders with Poor Flow Properties Introduction: In the realm of solid oral dosage…

Difficulty in preventing capsule deformation during shrink wrapping.

Difficulty in preventing capsule deformation during shrink wrapping. Difficulty in preventing capsule deformation during shrink wrapping. Introduction: In the pharmaceutical industry, ensuring the integrity of solid oral dosage forms such…

Poor alignment of capsules within blister packaging.

Poor alignment of capsules within blister packaging. Poor alignment of capsules within blister packaging. Introduction: Blister packaging is a widely used method in the pharmaceutical industry for the protection and…

Problems with validating cleaning procedures for encapsulation equipment.

Problems with validating cleaning procedures for encapsulation equipment. Problems with validating cleaning procedures for encapsulation equipment. Introduction: In the pharmaceutical industry, maintaining the cleanliness of manufacturing equipment is critical to…